For the Inventor, By the Inventor

Enter assignee name

Chicago, IL, United States of America

Tempus Ai, Inc.

USPTO Granted Patents = 36

EPO Patents = 12

Trademarks = 29

Forward Citations = 12

Loading Chart...

Loading Chart...

101 inventors (with patents filed for the assignee):

Aly Azeem Khan (6 out of 21 patents)

Ameen Salahudeen (5 out of 9 patents)

Jonathan Ozeran (5 out of 16 patents)

4. Eric Lefkofsky (5 out of 14 patents)

5. Catherine Igartua (4 out of 9 patents)

6. Jagadish Venkataraman (4 out of 36 patents)

7. Stephen Yip (3 out of 15 patents)

8. Robert Tell (3 out of 10 patents)

9. John Pfeifer (3 out of 5 patents)

10. Greg Lee (3 out of 7 patents)

11. Nike Beaubier (3 out of 3 patents)

12. Richard Blidner (2 out of 4 patents)

13. Brian M Larsen (2 out of 4 patents)

14. Michelle M Stein (2 out of 3 patents)

15. Madhavi Kannan (2 out of 4 patents)

36 patents: Sort by Forward Citations

1. 12738382 - ECG-based cardiovascular disease detection systems and related methods (2026-09-15),

2. 12731659 - Systems and methods for automating RNA expression calls in a cancer prediction pipeline (2026-09-08),

3. 12727863 - Detecting low ejection fraction from electrocardiogram data using artificial intelligence (2026-09-08),

4. 12718910 - Computer system and method for determining candidates for inclusion within a cohort (2026-08-25),

5. 12700508 - Artificial intelligence based cardiac event predictor systems and methods (2026-08-04),

6. 12694302 - Techniques for resolving discordant HER2 status in pathology images for diagnosing breast cancer (2026-07-28),

7. 12688906 - Methods of normalizing and correcting RNA expression data (2026-07-21),

8. 12683008 - Data-based mental disorder research and treatment systems and methods (2026-07-14),

9. 12682613 - Graph based metadata structuring algorithm to enable machine learning (2026-07-14),

10. 12676231 - Artificial intelligence assisted precision medicine enhancements to standardized laboratory diagnostic testing (2026-07-07),

11. 12663414 - Platform for co-culture imaging to characterize in vitro efficacy of heterotypic effector cellular therapies in cancer (2026-06-23),

12. 12618115 - Determination of cytotoxic gene signature and associated systems and methods for response prediction and treatment (2026-05-05),

13. 12603150 - Calculating cell-type RNA profiles for diagnosis and treatment (2026-04-14),

14. 12586391 - Systems and methods for deconvolving cell types in histology slide images, using super-resolution spatial transcriptomics data (2026-03-24),

15. 12584176 - INTEGRATED MACHINE-LEARNING FRAMEWORK TO ESTIMATE HOMOLOGOUS RECOMBINATION DEFICIENCY (2026-03-24),

Tempus Ai, Inc. is an innovative technology company specializing in artificial intelligence and machine learning solutions. Founded to harness the power of data analytics, Tempus Ai aims to improve decision-making processes across various sectors by providing cutting-edge AI tools. Their services include data integration, predictive modeling, and advanced analytics that empower businesses to optimize their operations. With a focus on healthcare, finance, and manufacturing industries, Tempus Ai utilizes proprietary algorithms and cloud-based platforms to deliver actionable insights that drive efficiency and growth. The team's expertise and commitment to excellence position Tempus Ai as a leader in the AI landscape, dedicated to transforming industries through technology.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

36 Patents

#133 in Chicago, IL

#530 in Illinois

#9,495 in US

#18,697 in the World

Chicago, IL, United States of America

Tempus Ai, Inc.

Forward Citations = 12

101 inventors:

Aly Azeem Khan (6 out of 21 patents)

Ameen Salahudeen (5 out of 9 patents)

Jonathan Ozeran (5 out of 16 patents)

4. Eric Lefkofsky (5 out of 14 patents)

5. Catherine Igartua (4 out of 9 patents)

Please report any incorrect information to [email protected]

Loading…